Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs
- PMID: 11682559
- PMCID: PMC88516
- DOI: 10.1128/JCM.39.11.4193-4195.2001
Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs
Abstract
Ninety-six enterococcus isolates from fecal samples of pigs receiving tylosin as an antimicrobial growth promoter and 59 isolates obtained in the same farms 5 to 6 months after the ban of antimicrobial growth promoters in Switzerland were tested for susceptibility to nine antimicrobial agents. A clear decrease in resistance to macrolides, lincosamides, and tetracycline was visible after the ban. Vancomycin-resistant Enterococcus faecium belonged to the same clonal lineage as vancomycin-resistant isolates previously isolated from Danish pigs.
Figures
References
-
- Aarestrup F M, Cartensen B. Effect of tylosin used as a growth promoter on the occurrence of macrolide resistant enterococci and staphylococci in pigs. Microb Drug Resist. 1998;4:307–312. - PubMed
-
- Aarestrup F M, Kruse H, Tast E, Hammerum A M, Jensen L B. Association between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway. Microb Drug Resist. 2000;6:63–70. - PubMed
-
- Aarestrup F M, Seyfarth A M, Emborg H-D, Pedersen K, Hendriksen R S, Bager F. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother. 2001;45:2054–2059. - PMC - PubMed
-
- Bager F, Aarestrup F M, Madsen M, Wegener H C. Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. Microb Drug Resist. 1999;5:53–56. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
